Both in Biotechnology
Gilead Sciences vs Neurocrine Biosciences
Over the past year GILD returned +42.5% and NBIX returned +2.0%; their daily moves had a correlation of 0.26.
GILD +42.5% NBIX +2.0%Growth of $1, one year, split-adjusted
| Metric | GILD | NBIX |
|---|---|---|
| Price | $170.68 | $146.10 |
| Market cap | $211.70B | $14.85B |
| Today | +3.06% | −0.19% |
| 1 month | +15.7% | +3.8% |
| 6 months | +29.6% | +10.9% |
| Year to date | +39.1% | +3.0% |
| 1 year | +44.0% | +5.9% |
| Revenue growth (YoY) | +6.8% | +39.5% |
| Gross margin | 81.1% | 97.6% |
| Net margin | 29.3% | 15.1% |
| P/E (TTM) | — | 21.1× |
| Price / sales | 6.8× | 4.4× |
| Net cash | -$19.79B | $389.8M |
| Dividend yield | 1.92% | — |
| Volatility (60d) | 25.5% | 26.3% |
| Short % of float | 1.6% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).